Micell Technologies Announces Issuance of Core Technology Patent Sacramento Bee This intellectual property protection is related to Micell's investigational MiStent® Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES™), as well as potential additional biomedical products. The patent rights are assigned to and ... |
